Evidence map›Paper›PMID 42607334›Full record

ArticleJournal of neurosurgery. Case lessons2026

De novo ruptured intracranial aneurysm associated with cerebral proliferative angiopathy: illustrative case.

Hiroki Suetsugu, Shun Okawa, Toshihiro Ishibashi, Shunsuke Hataoka, Yuichi Murayama

Abstract read
In one paragraph

Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hiroki SuetsuguDepartment of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan.
Shun OkawaDepartment of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan.
Toshihiro IshibashiDepartment of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan.ORCID 0000-0003-1044-5604
Shunsuke HataokaDepartment of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan.
Yuichi MurayamaDepartment of Neurosurgery, The Jikei University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCerebral proliferative angiopathy (CPA) is a distinct vascular entity different from arteriovenous malformation but remains exceedingly rare. The authors report a case of subarachnoid hemorrhage (SAH) caused by rupture of a de novo intracranial aneurysm arising in the setting of CPA. OBSERVATIONS: A 47-year-old female presented with headache and was transferred to the emergency department. Head CT revealed SAH (World Federation of Neurosurgical Societies grade III, Fisher group 3). Digital subtraction angiography showed diffuse vascular dilatation and arteriovenous shunting centered on the right middle cerebral artery (MCA). A newly developed aneurysm at the right posterior cerebral artery P1-P2 junction was treated by coil embolization to prevent rebleeding. Postoperatively, SPECT revealed right frontal hypoperfusion, and transcranial Doppler showed elevated flow velocity in the right MCA M1 segment consistent with vasospasm. The patient was discharged to rehabilitation with mild left upper limb paresis and cognitive impairment (modified Rankin Scale score 2). LESSONS: The authors present a rare case of CPA presenting with SAH and discuss the postoperative management of ruptured, flow-related aneurysms. Regular imaging follow-up is crucial to monitor for potential development of de novo aneurysm in CPA. https://thejns.org/doi/10.3171/CASE26216.

Indexed as

cerebral proliferative angiopathycoil embolizationendovascular treatmentflow-related aneurysmsubarachnoid hemorrhage

Identifiers

PMID42607334
PMCPMC13479768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.